908 Devices (MASS) Non-Current Deffered Revenue (2020 - 2026)
908 Devices (MASS) posted quarterly Non-Current Deffered Revenue of $9.1 million for Q1 2026, down 5.0% year-over-year from $9.5 million in Q1 2025, and up 8.85% quarter-over-quarter from $8.3 million in Q4 2025.
908 Devices (MASS) Non-Current Deffered Revenue (2020 - 2026) Analysis & Trends
908 Devices (MASS) has reported Non-Current Deffered Revenue for 7 consecutive years, with $9.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Deffered Revenue fell 5.0% year-over-year to $9.1 million; the TTM figure through Mar 2026 stood at $9.1 million (down 5.0% YoY), while the FY2025 annual figure was $8.3 million, down 18.43% from the prior year.
- Non-Current Deffered Revenue improved to $9.1 million in Q1 2026 per MASS's latest filing, from $8.3 million in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $12.2 million in Q3 2022 and bottomed at $7.9 million in Q1 2024.
- Historically, Non-Current Deffered Revenue has averaged $9.9 million across 5 years, with a median of $9.5 million in 2024.
- Annual changes were most pronounced in 2022 — Non-Current Deffered Revenue soared 41.27% — and 2024, when it fell 27.72%.
- 908 Devices' Non-Current Deffered Revenue stood at $11.5 million in 2022, then retreated by 25.44% to $8.6 million in 2023, then increased by 19.16% to $10.2 million in 2024, then slipped by 18.43% to $8.3 million in 2025, then grew by 8.85% to $9.1 million in 2026.
- Business Quant data shows MASS's Non-Current Deffered Revenue at $9.1 million in Q1 2026, $8.3 million in Q4 2025, and $9.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 539.34 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | - |
| 10 | 908 Devices | 398.03 Mn | 296.50 Mn | 8.34 Mn | 11.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.01 Mn |
| Mar 31, 2026 | 9.07 Mn |
| Dec 31, 2025 | 8.33 Mn |
| Sep 30, 2025 | 9.19 Mn |
| Jun 30, 2025 | 9.18 Mn |
| Mar 31, 2025 | 9.55 Mn |
| Dec 31, 2024 | 10.21 Mn |
| Sep 30, 2024 | 11.03 Mn |
| Jun 30, 2024 | 9.53 Mn |
| Mar 31, 2024 | 7.87 Mn |
| Dec 31, 2023 | 8.57 Mn |
| Sep 30, 2023 | 9.37 Mn |
| Jun 30, 2023 | 8.47 Mn |
| Mar 31, 2023 | 10.89 Mn |
| Dec 31, 2022 | 11.50 Mn |
| Sep 30, 2022 | 12.16 Mn |
| Jun 30, 2022 | 11.65 Mn |
| Mar 31, 2022 | 11.60 Mn |
| Dec 31, 2021 | 11.96 Mn |
| Sep 30, 2021 | 10.41 Mn |